You Invested to Meet the Demand for COVID-19 Testing: How Do You Optimize that Investment Post-Pandemic?

At the beginning of the COVID-19 pandemic in the U.S., many laboratories invested in equipment, supplies, and personnel to manage the surge of COVID-19 test demand. For the laboratory information system (LIS), the backbone of the laboratory IT infrastructure, this meant new workflows, report templates, and instrument interfaces to handle the new COVID-19 Polymerase Chain Reaction (PCR) tests.Once...

Read


Five Steps to Capture Lost Revenue for Hospital Outreach and Outpatient Services | Part 5: Sharpen Focus on Stakeholder Access and Engagement

This blog post is the final installment of our five part series. View Part One, Part Two, Part Three, Part Four. Pressure on hospitals and health systems to promote transparency, access, and engagement for patients and physicians is accelerating on multiple fronts. For example, as of January 1st 2021, CMS requires hospitals to post specific pricing data for at least 300 “shoppable services” in...

Read


CFO Perspective: Boosting Outpatient Profit with Optimized RCM

Many health system and hospital executives look to outreach, outpatient, and ancillary services to impact their organization's cost structure and quality performance.However, these organizations typically employ EHR systems designed for inpatient service revenue cycle management. This leads to reduced visibility into key outpatient RCM problem areas and metrics that enable critical decision-...

Read


Five Steps to Capture Lost Revenue for Hospital Outreach and Outpatient Services | Part 4: Establish Universal Compliance in RCM

This blog post is part four of a five part series. View Part One, Part Two, Part Three. Running afoul of regulatory compliance requirements is a significant concern for hospital administrators and finance leaders—with good reason: the consequences can be steep. For example, in June 2020, a Georgia-based hospital system agreed to pay $16 million to settle multiple allegations of violating the...

Read


University of Southern California (USC) Department of Pathology and Laboratory Medicine — An Outreach Success Story

The University of Southern California (USC) Department of Pathology and Laboratory Medicine is one of the largest and most acclaimed in the country, with nationally and internationally renowned physicians on its staff. When the team at USC decided to open an outreach laboratory to expand their lab services to the community, the department chose XIFIN, Inc. as its pathology laboratory information...

Read


4 Ways to Maximize Revenue Regarding Genetic Testing

As genetic testing has continued to increase, reimbursements on genetic test claims remain a significant challenge for clinical laboratories and anatomic pathology groups.According to Concert Genetics, the number of total genetic tests in 2012 was 10,000. By year-end 2020, that number had grown to 166,450 tests. Not only is the number of tests increasing, but the testing is becoming more...

Read


Five Steps to Capture Lost Revenue for Hospital Outreach and Outpatient Services | Part 3: Capture and Exploit the Right Data

This blog post is part three of a five part series. View Part One and Part Two. In this series, we’ve explored the substantive topline and bottom-line impacts of front-end revenue cycle automation and enhanced claim denial management capabilities. Next, we look at capturing and exploiting the right data, to help regain lost outpatient revenue. Faced with the pronounced fiscal impacts of Covid-19...

Read


The Value of Payor-Specific Appeals Automation

Clarisa BlattnerSenior Director MDx Support Services, XIFIN Scott BurkClient Success Manager, XIFIN The growing number of appeals and the high costs associated with them is a challenge for many laboratories and diagnostic providers. These costs are exacerbated if the laboratory uses a traditional...

Read